The company Novatin s.r.o was founded in 2007 and at the very beginning it began with the distribution of medical devices for patients with diabetes. We have gradually expanded our range with POCT (Point of Care Tests) analysers corresponding to the latest knowledge and trends in this area (eg HbA1c examination, chemical urine examination).
Within the time of our existence, we have gradually built a stable position in the Czech Republic, not only due to our extensive range of products in this sector, but also due to our efforts to help patients. With our determination to bring patients the best products, in 2017 we also included medicaments into our portfolio in order to provide comprehensive treatment in the field of diabetes.
In 2018, we decided to expand our area of interest to the field of oncology. Currently in our range of products, you can find 2 drugs that help cancer patients.
In 2020, we also launched on the Czech market the first biosimilar low molecular weight heparin and with the onset of the COVID-19 pandemic a complete portfolio of products for collection and detection of coronavirus SARS-CoV-2. In our range you will find not only rapid antigen tests, but also PCR tests for the detection of the coronavirus SARS-CoV-2.
We have also extended our activities to other areas of the EU. You can find our products in Croatia, Spain and other countries.
In addition to marketing and distribution of our products, we are also involved in organising professional workshops and other educational events.